Industry-Focused Panel Discussion

Time: 5:00 pm
day: Day One

Details:

During development of new immuno-modulatory therapeutics, when is the best time to evaluate cytokine release?

Options include:

  • As a stand-alone assay comparing molecules in a side-by-side assay for lead
    selection
  • During analysis of preclinical efficacy as part of the overall mode of action
  • Later stage, post preclinical efficacy to determine safety/tox prior to IND filing.

Speakers: